Unknown NA INTERVENTIONAL 2-arm NCT06148233

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

Sponsor: Huashan Hospital

Conditions Alzheimer Disease Neurodegenerative Diseases Positron Emission Tomography

Interventions [18F]CSF-23

Updated 4 times since 2023 Last updated: Nov 19, 2023 Started: Sep 15, 2023 Primary completion: Jun 16, 2024 Completion: Sep 14, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alzheimer Disease and Neurodegenerative Diseases and is currently ongoing. Huashan Hospital leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Dec 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital

Data source: Huashan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China